Junqiao Chen has nine years of healthcare industry experience in the United States and Asia. He is a published author in international academic journals on system thinking and modeling, and is a regular contributor to Hong Kong media such as HK01 and Ming Pao. He hosts an ecosystem partnership position at a multinational biotech company. Opinions in this article are all his and the co-author’s, and do not represent his employer. With a master of management degree in clinical informatics from Duke University and a master of science in evidence-based healthcare from University of Oxford, he is a non-resident PhD student in complexity science, a joint program of the ISCTE - Instituto Universitário de Lisboa and the University of Lisbon.
China’s National 14th Five-Year Plan positions Hong Kong as a global innotech hub, with biotechnology identified as one of the city’s most promising sectors.
AsiaGlobal Online ends publication as of August 10, 2023
Check out here for more research and analysis from Asian perspectives.